StonvexLoading…
StonvexStonvexStonvexCore line items from BOF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.61M | $13.72M | $9.71M | $6.49M |
Operating Income | $-1.62M | $-5.36M | $-3.46M | $-2.03M |
Net Income | $-1.79M | $-6.12M | $-4.09M | $-2.52M |
EPS (Diluted) | $-0.12 | $-0.57 | $-0.41 | $-0.27 |
Total Assets | $17.17M | $14.46M | $14.66M | $13.15M |
Total Liabilities | $11.24M | $8.89M | $9.54M | $9.61M |
Cash & Equivalents | $0.00 | $0.00 | $0.00 | $0.00 |
Free Cash Flow OCF − CapEx | $-2.61M | $-7.75M | $-5.64M | $-4.43M |
Shares Outstanding | 14.58M | 13.39M | 12.23M | 10.72M |